Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

GeoVax Labs Inc (GOVX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow GeoVax Labs's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.5400 -0.1500    -8.88%
24/04 - Closed. Currency in USD ( Disclaimer )
After Hours
1.5000
-0.0400
-2.5974%
19:30:53 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 34,763
  • Bid/Ask: 1.4900 / 1.6400
  • Day's Range: 1.4800 - 1.6400
GeoVax Labs 1.5400 -0.1500 -8.88%

GeoVax Labs Inc Company Profile

 
Get an in-depth profile of GeoVax Labs Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

17

Equity Type

ORD

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; other infectious disease vaccines for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.

Contact Information

Address 1900 Lake Park Drive Suite 380
Smyrna, 30080
United States
Phone 678 384 7220
Fax 678 384 7281

Top Executives

Name Age Since Title
Valerie Montgomery Rice - - Director & Special Advisor to the Chairman and CEO
David Alan Dodd 74 2010 Chairman, President & CEO
Harriet Latham Robinson 86 2001 Founder, Chief Scientific Officer Emeritus & Member of Scientific Advisory Board
Dean G. Kollintzas 51 2006 Independent Director
Barney S. Graham - - Member of Scientific Advisory Board
Stanley A. Plotkin 91 - Member of Scientific Advisory Board
John N. Spencer 83 2006 Independent Director
Robert T. McNally 76 2006 Independent Director
Scott C. Weaver - - Member of Scientific Advisory Board
Olivera J. Finn - - Member of Scientific Advisory Board
Randal D. Chase 74 2015 Independent Director
Nicole Lemerond 48 2022 Independent Director
Jayne Morgan 60 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GOVX Comments

Write your thoughts about GeoVax Labs Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Carlos Carranza
Carlos Carranza Jan 30, 2024 1:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This sc4 . m tommorow 1$ . Tr4h . Who win ? Only ceo
Matias Marquez
Matias Marquez Jan 30, 2024 1:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
reverse split 1$ but all People lost your money because they have less shares and need price high . is scam as MULN and BLUe apron
Matias Marquez
Matias Marquez Jan 23, 2024 9:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this tr4sh is r.i.p , is the same Muln and amc . the ceo is a big Winer olny him . Remember this .
Matias Marquez
Matias Marquez Sep 22, 2022 1:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this tras Will 0.5$-0.4 , for years . trash .
Dany Sanchez
Dany Sanchez Sep 16, 2022 10:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
BELOW $1 TODAY OR MONDAY CLOSE gap IN 0.6$
Matius Marv
Matius Marv Sep 16, 2022 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
EXPIRATION OF FUTURES , ALL READY VVV COMING , SEE
Matias Marquez
Matias Marquez Sep 01, 2022 10:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
we Will close gap in 0.5$. geovax always play with fake news for trap bu..l.ls then Big red. close gap go
Giuseppe Giannachi
Giuseppe Giannachi Aug 03, 2022 12:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what time are earnings
Dany Sanchez
Dany Sanchez Aug 03, 2022 10:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
below $1. Sad , big bul-l trap
Matias Marquez
Matias Marquez Aug 02, 2022 9:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big red . i told You gov x always play with the news. close first Gap . we have 2 Gaps more. down
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email